Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /HIKAL
chevron_leftBack

Hikal Ltd.

HIKAL
NSE: HIKAL Delayed
416.90INR 1.5%
4.88 USD
As of 24 April 2025, Hikal Ltd. has a market cap of $593.81M USD, ranking #10932 globally and #739 in India. It ranks #1067 in the Healthcare sector, and #257 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
10932
Country Rank
739
Sector Rank
1067
Industry Rank
257
Key Stats
Market Cap
$593.81MUSD
50.67B INR
Enterprise Value
$679.06MUSD
58.06B INR
Revenue (TTM)
$213.46MUSD
18.22B INR
EBITDA (TTM)
$34.36MUSD
2.94B INR
Net Income (TTM)
$8.74MUSD
746.02M INR
EBITDA Margin
16%
Profit Margin
4.1%
PE Ratio
67.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sameer Hiremath open_in_new
Employees
2,061
Founded
1988
Website
hikal.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.5% -1.9% 0.1% 10% 11% 38%
Upcoming Earnings
Earnings Date
Fri, May 9

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
HIKAL
Hikal Ltd
ISIN: INE475B01022
Shares Out.:
123.301M1 Shares Float: 38.805M2
TV:
SA:
YF:
GF:
BA:
MS:
416.90 INR
Bombay Stock Exchange
MIC: XBOM
524735 (HIKAL)
Hikal Ltd
ISIN: INE475B01022
TV:
SA:
YF:
GF:
BA:
MS:
424.20 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Hikal Ltd.

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
8K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
3K%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
2K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
2K%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
2K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
11K%
Merck KGaA
MRK
$59.42B
52.43B EUR
10K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
8K%
Haleon plc
HLN
$45.57B
34.34B GBP
8K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
4K%